Ventricular arrhythmias: From the electrophysiology laboratory to clinical practice part I: Malignant ventricular arrhythmias

Hellenic Journal of Cardiology

Volumn 52, Issue 6, 2011, Pages 525-535

  Gatzoulis, Konstantinos A ^a   Archontakis, Stefanos ^a   Dilaveris, Polychronis ^a   Tsiachris, Dimitrios ^a   Arsenos, Petros ^a   Sideris, Skevos ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Automatic implantable cardioverterdefibrillators; Electrophysiological study; Malignant ventricular tachyarrhythmias; Risk stratification for sudden cardiac death

Indexed keywords

CLINICAL PRACTICE; DEFIBRILLATOR; ELECTROCARDIOGRAM; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; REVIEW;

ELECTROCARDIOGRAPHY; HUMANS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 83055163357     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Morganroth J. Premature ventricular complexes. Diagnosis and indications for therapy. JAMA. 1984; 252: 673-676.
2. Bigger JT. Identification of patients at high risk for sudden cardiac death. Am J Cardiol. 1984; 54: 3D-8D.
3. Morganroth J, Bigger JT. Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial. Am J Cardiol. 1990; 65: 1497-1503.
4. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971; 44: 130-142.
5. Wellens HJ, Brugada P. Treatment of cardiac arrhythmias: when, how and where? J Am Coll Cardiol. 1989; 14: 1417-1428.
6. Horowitz ZN, Spielman SR, Greenspan AM, Josephson ME. Role of programmed stimulation in assessing vulnerability to ventricular arrhythmias. Am Heart J. 1982; 103: 604-610.
7. Morady F, Scheinman MM, Hess DS, Sung RJ, Shen E, Shapiro W. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. Am J Cardiol. 1983; 51: 85-89.
8. Calkins H, Kalbfleisch SJ, el-Atassi R, Langberg JJ, Morady F. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol. 1993; 71: 827-833.
9. Bogun F, Bahu M, Knight BP, et al. Comparison of effective and ineffective target sites that demonstrate concealed entrainment in patients with coronary artery disease undergoing radiofrequency ablation of ventricular tachycardia. Circulation. 1997; 95: 183-190.
10. Morady F, Harvey M, Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993; 87: 363-372.
11. Waldo AL, Henthorn RW. Use of transient entrainment during ventricular tachycardia to localize a critical area in the reentry circuit for ablation. Pacing Clin Electrophysiol. 1989; 12: 231-244.
12. Blanck Z, Dhala A, Deshpande S, Sra J, Jazayeri M, Akhtar M. Catheter ablation of ventricular tachycardia. Am Heart J. 1994; 127: 1126-1133.
13. Haissaguerre M, Warin JF, Lemétayer P, Guillem JP, Blanchot P. Fulguration of ventricular tachycardia using high cumulative energy: results in thirty-one patients with a mean follow-up of twenty-seven months. Pacing Clin Electrophysiol. 1989; 12: 245-251.
14. Volkmann H, Kühnert H, Dannberg G, Heinke M. Bundle branch reentrant tachycardia treated by transvenous catheter ablation of the right bundle branch. Pacing Clin Electrophysiol. 1989; 12: 258-261.
15. Willems S, Borggrefe M, Shenasa M, et al. Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator. Pacing Clin Electrophysiol. 1993; 16: 1684-1692.
16. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993; 88: 1647-1670.
17. Waldo AL. From bedside to bench: entrainment and other stories. Heart Rhythm. 2004; 1: 94-106.
18. Waldo AL, Henthorn RW, Plumb VJ, MacLean WA. Demonstration of the mechanism of transient entrainment and interruption of ventricular tachycardia with rapid atrial pacing. J Am Coll Cardiol. 1984; 3: 422-430.
19. Nogami A, Naito S, Tada H, et al. Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. J Am Coll Cardiol. 2000; 36: 811-823.
20. Nakagawa H, Beckman KJ, McClelland JH, et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation. 1993; 88: 2607-2617.
21. Ouyang F, Cappato R, Ernst S, et al. Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network. Circulation. 2002; 105: 462-469.
22. Della Bella P, Pappalardo A, Riva S, Tondo C, Fassini G, Trevisi N. Non-contact mapping to guide catheter ablation of untolerated ventricular tachycardia. Eur Heart J. 2002; 23: 742-752.
23. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997; 337: 1576-1583.
24. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996; 335: 1933-1940.
25. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000; 21: 2071-2078.
26. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346: 877-883.
27. Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc. 2009; 84: 289-297.
28. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008; 51: e1-62.
29. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005; 352: 2581-2588.
30. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol. 2005; 14: 71-78.
31. Bella PD, Riva S. Hybrid therapies for ventricular arrhythmias. Pacing Clin Electrophysiol. 2006; 29 Suppl 2: S40-47.
32. Sacher F, Tedrow UB, Field ME, et al. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol. 2008; 1: 153-161.
33. Pedrinazzi C, Durin O, Agricola P, Romagnoli P, Inama G. Efficacy and safety of radiofrequency catheter ablation in the elderly. J Interv Cardiac Electrophisiol. 2007; 19: 179-85.
34. Dagres N, Piorkowski C, Kottkamp H, Kremastinos DT, Hindricks G. Contemporary catheter ablation of arrhythmias in geriatric patients: patient characteristics, distribution of arrhythmias, and outcome. Europace. 2007; 9: 477-480.
35. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007; 357: 2657-2665.
36. Kuck KH, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010; 375: 31-40.
37. Das MK, Scott LR, Miller JM. Focal mechanism of ventricular tachycardia in coronary artery disease. Heart Rhythm. 2010; 7: 305-311.
38. Eckardt L, Breithardt G. Catheter ablation of ventricular tachycardia. From indication to three-dimensional mapping technology. Herz. 2009; 34: 187-196.
39. Villacastín J, Almendral J, Arenal A, et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation. 1996; 93: 753-762.
40. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol. 1998; 32: 1909-1915.
41. Exner DV, Pinski SL, Wyse DG, et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001; 103: 2066-2071.
42. Gatzoulis KA, Sideris SK, Kallikazaros IE, Stefanadis CI. Electrical storm: a new challenge in the age of implantable defibrillators. Hellenic J Cardiol. 2008; 49: 86-91.
43. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace. 2000; 2: 263-269.
44. Verma A, Kilicaslan F, Marrouche NF, et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol. 2004; 15: 1265-1270.
45. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, et al. Electrical storm is an independent predictor of adverse longterm outcome in the era of implantable defibrillator therapy. Europace. 2005; 7: 184-192.
46. Sesselberg HW, Huang DT, Zareba W, et al. Storms of ventricular tachycardia/fibrillation in MADIT II patients. Heart Rhythm. 2005; 2: S205.
47. Arya A, Haghjoo M, Dehghani MR, et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol. 2006; 97: 389-392.
48. Brigadeau F, Kouakam C, Klug D, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J. 2006; 27: 700-707.
49. Hohnloser SH, Al-Khalidi HR, Pratt CM, et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J. 2006; 27: 3027-3032.
50. Nayak HM, Verdino RJ, Russo AM, et al. Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome. J Cardiovasc Electrophysiol. 2008; 19: 708-715.
51. Soman SS, Sandberg KR, Borzak S, Hudson MP, Yee J, Mc-Cullough PA. The independent association of renal dysfunction and arrhythmias in critically ill patients. Chest. 2002; 122: 669-677.
52. McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000; 36: 679-684.
53. Raitt MH, Klein RC, Wyse DG, et al. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol. 2003; 91: 812-816.
54. Gomes JA, Cain ME, Buxton AE, Josephson ME, Lee KL, Hafley GE. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation. 2001; 104: 436-441.
55. Bänsch D, Oyang F, Antz M, et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation. 2003; 108: 3011-3016.
56. Silva RM, Mont L, Nava S, Rojel U, Matas M, Brugada J. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004; 27: 971-975.
57. Schreieck J, Zrenner B, Deisenhofer I, Schmitt C. Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias. Heart Rhythm. 2005; 2: 10-14.
58. Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation. 2008; 117: 462-469.
59. Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation. 2005; 111: 2898-2905.
60. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation. 1997; 95: 1611-1622.
61. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352: 225-237.
62. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA. 2004; 292: 2874-2879.
63. Camm AJ, Nisam S. European utilization of the implantable defibrillator: has 10 years changed the 'enigma'? Europace. 2010; 12: 1063-1069.
64. Simson MB. Effects of surgery for control of ventricular tachycardia on late potentials. Circulation. 1981; 64 (IV): 88.
65. Breithardt G, Seipel L, Ostermeyer J, et al. Effects of antiarrhythmic surgery on late ventricular potentials recorded by precordial signal averaging in patients with ventricular tachycardia. Am Heart J. 1982; 104: 996-1003.
66. Marcus NH, Falcone RA, Harken AH, Josephson ME, Simson MB. Body surface late potentials: effects of endocardial resection in patients with ventricular tachycardia. Circulation. 1984; 70: 632-637.
67. Borggrefe M, Breithardt G. Is the implantable defibrillator indicated in patients with hypertrophic cardiomyopathy and aborted sudden death? J Am Coll Cardiol. 1998; 31: 1086-1088.